Canada markets closed

Intra-Cellular Therapies, Inc. (ITCI)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
79.84+15.08 (+23.29%)
At close: 04:00PM EDT
78.00 -1.84 (-2.30%)
After hours: 05:01PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
462,175
462,175
249,132
81,708
22,531
Cost of Revenue
33,745
33,745
20,443
8,035
1,895
Gross Profit
428,430
428,430
228,689
73,673
20,636
Operating Expenses
Research Development
180,142
180,142
134,715
88,845
65,782
Selling General and Administrative
409,864
409,864
358,782
272,611
186,364
Total Operating Expenses
587,811
587,811
492,315
359,361
251,864
Operating Income or Loss
-159,381
-159,381
-263,626
-285,688
-231,228
Income Before Tax
-139,038
-139,038
-256,250
-284,120
-226,992
Income Tax Expense
636
636
6
6
14
Income from Continuing Operations
-139,674
-139,674
-256,256
-284,126
-227,006
Net Income
-139,674
-139,674
-256,256
-284,126
-227,006
Net Income available to common shareholders
-139,674
-139,674
-256,256
-284,126
-227,006
Basic EPS
-1.62
-
-2.72
-3.50
-3.23
Diluted EPS
-1.62
-
-2.72
-3.50
-3.23
Basic Average Shares
95,499
-
94,047
81,253
70,365
Diluted Average Shares
95,499
-
94,047
81,253
70,365